Influence of mental stress and environmental toxins on circadian clocks: Implications for redox regulation of the heart and cardioprotection.

Journal: British journal of pharmacology

Volume: 177

Issue: 23

Year of Publication: 2021

Affiliated Institutions:  Department of Pharmacology, Medical Center of the Johannes Gutenberg University, Mainz, Germany. Division Heart and Lungs and Regenerative Medicine Centre, University Medical Centre Utrecht and Utrecht University, Utrecht, Netherlands. Center of Cardiology , Molecular Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany. Structural Chronobiology, Institute of Molecular Physiology, Johannes Gutenberg University, Mainz, Germany. Hatter Institute for Cardiovascular Research in Africa, University of Cape Town, Cape Town, South Africa. Institute for Physiology, Justus-Liebig University Giessen, Giessen, Germany.

Abstract summary 

Risk factors in the environment such as air pollution and mental stress contribute to the development of chronic non-communicable disease. Air pollution was identified as the leading health risk factor in the physical environment, followed by water pollution, soil pollution/heavy metals/chemicals and occupational exposures, however neglecting the non-chemical environmental health risk factors (e.g. mental stress and noise). Epidemiological data suggest that environmental risk factors are associated with higher risk for cardiovascular, metabolic and mental diseases, including hypertension, heart failure, myocardial infarction, diabetes, arrhythmia, stroke, depression and anxiety disorders. We provide an overview on the impact of the external exposome comprising risk factors/exposures on cardiovascular health with a focus on dysregulation of stress hormones, mitochondrial function, redox balance and inflammation with special emphasis on the circadian clock. Finally, we assess the impact of circadian clock dysregulation on cardiovascular health and the potential of environment-specific preventive strategies or "chrono" therapy for cardioprotection. LINKED ARTICLES: This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.23/issuetoc.

Authors & Co-authors:  Li Huige H Kilgallen Aoife B AB Münzel Thomas T Wolf Eva E Lecour Sandrine S Schulz Rainer R Daiber Andreas A Van Laake Linda W LW

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Alexander, S. P. , Kelly, E. , Mathie, A. , Peters, J. A. , Veale, E. L. , Armstrong, J. F. , et al. (2019). The Concise Guide to PHARMACOLOGY 2019/20: Introduction and other protein targets. British Journal of Pharmacology, 176, S1–S120. 10.1111/bph.14747
Authors :  8
Identifiers
Doi : 10.1111/bph.14949
SSN : 1476-5381
Study Population
Male,Female
Mesh Terms
Cardiovascular System
Other Terms
Study Design
Cross Sectional Study
Study Approach
Country of Study
Publication Country
England